Holdings of First Trust Nasdaq Pharmaceuticals ETF
First Trust Exchange-Traded Fund VI · Original filing · Compare with another fund · Report an error
- Net assets
- 36.2M $ including 36.2M $ in equities, 99.9 %
- Positions
- 50 in 3 countries
- Top ten
- 53.1 % of net assets
- Filed on
- Jun 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 2,347 | 2.8M $ | 7.77 % |
| 2 | AbbVie Inc | 10,640 | 2.7M $ | 7.39 % |
| 3 | Merck & Co Inc | 19,942 | 2.6M $ | 7.07 % |
| 4 | Johnson & Johnson | 9,939 | 2.5M $ | 6.96 % |
| 5 | Bristol-Myers Squibb Co | 39,590 | 2.3M $ | 6.29 % |
| 6 | Biogen Inc | 6,436 | 1.4M $ | 3.84 % |
| 7 | VIATRIS INC | 82,694 | 1.3M $ | 3.62 % |
| 8 | Cardinal Health Inc | 5,386 | 1.3M $ | 3.53 % |
| 9 | Vertex Pharmaceuticals Inc | 2,485 | 1.2M $ | 3.41 % |
| 10 | Amgen Inc | 3,181 | 1.2M $ | 3.18 % |
| 11 | Pfizer Inc | 44,652 | 1.1M $ | 2.97 % |
| 12 | Gilead Sciences Inc | 8,289 | 1M $ | 2.89 % |
| 13 | United Therapeutics Corp | 1,822 | 987.2K $ | 2.72 % |
| 14 | Regeneron Pharmaceuticals Inc | 1,579 | 984.6K $ | 2.72 % |
| 15 | JAZZ PHARMACEUTICALS PLC | 3,741 | 901.5K $ | 2.49 % |
| 16 | Incyte Corp | 7,648 | 867K $ | 2.39 % |
| 17 | Illumina Inc | 4,088 | 718.8K $ | 1.98 % |
| 18 | Zoetis Inc | 9,417 | 676.7K $ | 1.87 % |
| 19 | Exelixis Inc | 11,488 | 625.1K $ | 1.72 % |
| 20 | Charles River Laboratories International Inc | 2,377 | 539.1K $ | 1.49 % |
| 21 | Medpace Holdings Inc | 966 | 511.6K $ | 1.41 % |
| 22 | PTC Therapeutics Inc | 6,091 | 496.8K $ | 1.37 % |
| 23 | Neurocrine Biosciences Inc | 2,939 | 495.3K $ | 1.37 % |
| 24 | Alkermes PLC | 9,366 | 490.7K $ | 1.35 % |
| 25 | Halozyme Therapeutics Inc | 5,593 | 437.8K $ | 1.21 % |
| 26 | BioMarin Pharmaceutical Inc | 7,061 | 404K $ | 1.11 % |
| 27 | TWIST BIOSCIENCE CORP | 3,619 | 372.3K $ | 1.03 % |
| 28 | Spyre Therapeutics Inc | 3,948 | 350.5K $ | 0.97 % |
| 29 | TRAVERE THERAPEUTICS INC | 5,700 | 323.8K $ | 0.89 % |
| 30 | TG THERAPEUTICS INC | 5,643 | 310K $ | 0.86 % |
| 31 | ELANCO ANIMAL HEALTH INC | 12,210 | 300.5K $ | 0.83 % |
| 32 | 10X Genomics Inc | 7,367 | 282.5K $ | 0.78 % |
| 33 | GUARDANT HEALTH INC | 1,808 | 271.3K $ | 0.75 % |
| 34 | Ligand Pharmaceuticals Inc | 856 | 270.6K $ | 0.75 % |
| 35 | ARCUS BIOSCIENCES INC | 8,336 | 257K $ | 0.71 % |
| 36 | Amneal Pharmaceuticals Inc | 14,511 | 251.2K $ | 0.69 % |
| 37 | Arrowhead Pharmaceuticals Inc | 2,918 | 237.8K $ | 0.66 % |
| 38 | Catalyst Pharmaceuticals Inc | 7,357 | 231.2K $ | 0.64 % |
| 39 | Krystal Biotech Inc | 616 | 228.9K $ | 0.63 % |
| 40 | Protagonist Therapeutics Inc | 1,844 | 226K $ | 0.62 % |
| 41 | MODERNA INC | 3,170 | 222K $ | 0.61 % |
| 42 | MIRUM PHARMACEUTICALS INC | 1,840 | 215.4K $ | 0.59 % |
| 43 | KYMERA THERAPEUTICS INC | 1,859 | 213.2K $ | 0.59 % |
| 44 | Roivant Sciences Ltd | 5,868 | 207.7K $ | 0.57 % |
| 45 | ACADIA Pharmaceuticals Inc | 6,914 | 174.9K $ | 0.48 % |
| 46 | IONIS PHARMACEUTICALS INC | 2,093 | 166K $ | 0.46 % |
| 47 | Arcutis Biotherapeutics Inc | 6,296 | 165.1K $ | 0.46 % |
| 48 | ALNYLAM PHARMACEUTICALS INC | 510 | 153.5K $ | 0.42 % |
| 49 | Supernus Pharmaceuticals Inc | 3,103 | 144.3K $ | 0.40 % |
| 50 | TARSUS PHARMACEUTICALS INC | 2,249 | 141.6K $ | 0.39 % |
Sector breakdown
- Health care 73.0 %
- Unattributed 27.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 95.6 %
- Ireland 3.8 %
- Bermuda 0.6 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 47 | 34.6M $ | 95.58 % |
| 2 | Ireland | 2 | 1.4M $ | 3.85 % |
| 3 | Bermuda | 1 | 207.7K $ | 0.57 % |
Cite this page
Titelia. "Holdings of First Trust Nasdaq Pharmaceuticals ETF". https://titelia.com/en/funds/S000053945